Hazard ratio (HR) for disease progression analysis comparing TMB-high with TMB-low in three NSCLC datasets

Hazard ratio (HR) for disease progression analysis comparing TMB-high with TMB-low in three NSCLC datasets

Format

a data.frame

Source

Wang, Shixiang, et al. "The predictive power of tumor mutational burden in lung cancer immunotherapy response is influenced by patients' sex." International journal of cancer (2019).

Examples

data("wang2019")